CURE5h
Presurgical Opdivo Plus Yervoy Has Potential Clinical Benefit in NSCLC
Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical ...
CURE7h
What’s On the Horizon for Small Cell Lung Cancer Research?
As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.
CURE7h
What the FDA Approval of Bizengri Means for Patients With NRG1-Positive NSCLC
The FDA granted its first approval for a systemic therapy for patients with non-small cell lung cancer with an Neuregulin 1 ...
CURE7h
How the FDA Approval of Imfinzi Advances Small Cell Lung Cancer Treatment
The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...
CURE7h
FDA Approval of Ensacove Adds to the Toolkit for ALK-Positive NSCLC
An expert explained the importance of the FDA’s approval of Ensacove for patients with ALK-positive non-small cell lung ...
CURE9h
A Patient’s Journey With Colon Cancer and Her Advocacy Mission
Melissa Ursini, diagnosed with stage 2 colon cancer, shares her journey to raise awareness and encourage early detection ...
CURE9h
Looking For The Light After MDS
As cancer survivors, we all know how the dark times roll. We have gone through the shock of the diagnosis, facing the fear of ...
CURE13h
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal ...
CURE10h
What Patients Need to Know About Appealing Insurance Denials
The ceo of triage cancer discussed the “best-kept secret” of the health care system in an interview with cure.